Table 1 Characteristics of the study patient participants (n = 158)
Age, mean (SD), years | 69.9 (11.9) |
Female sex | 71 (44.9%) |
NT-proBNP, ng/L, median (IQR) | 195 (738) |
Body mass index in kg/m2, mean (SD) | 28.2 (4.2) |
Medical history, n/N (%) | |
Chronic Heart failure, medication for | 34/158 (21.5%) |
Hypertension, medication for | 97/158 (61.4%) |
Diabetes mellitus, treatment for | 28/158 (17.7%) |
Dyslipidaemia, medication for | 55/158 (34.8%) |
Asthma or COPD | 24/158 (15.2%) |
Revascularisation | 21/158 (13.3%) |
AMI | 16/157 (10.2%) |
Stroke or TIA | 18/158 (11.4%) |
Symptoms, n/N (%) | |
Orthopnea | 23/157 (14.6%) |
Nocturnal dyspnoea | 30/158 (19.0%) |
Ankle oedema | 50/158 (31.6%) |
Limitation of physical activity (NYHA I-IV), n/N (%) | |
No limitation of physical activity | 65/156 (41.7%) |
Slight limitation of physical activity | 59/156 (37.8%) |
Marked limitation of physical activity | 29/156 (18.6%) |
Discomfort with any physical activity/ symptoms occurring even at rest | 3/156 (1.9%) |
Exertional chest pain, n/N (%) | 50/155 (32.3%) |